Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
7 of the Most Shocking M&A Rumors in Medtech
Medical Devices and Diagnostics Industry
Thu, 08/4/22 - 06:38 pm
Medtech
M&A
DexCom
Insulet
Medtronic
LivaNova
Baxter
Hill-Rom
Stryker
Boston Scientific
Illumina
Grail
Guardant Health
NeoGenomics
Smith & Nephew
Amgen, on an M&A spree, inks $3.7B ChemoCentryx buyout to boost inflammatory disease presence
Fierce Pharma
Thu, 08/4/22 - 12:10 pm
Amgen
M&A
patent cliff
ChemoCentryx
ResMed Strengthens Sleep Portfolio with Mementor Acquisition
Medical Devices and Diagnostics Industry
Wed, 08/3/22 - 09:36 pm
ResMed
Mementor
insomnia
M&A
digital therapeutics
After delay, CSL's $11.7B deal for Vifor poised to close next week
Fierce Pharma
Tue, 08/2/22 - 10:39 am
M&A
CSL
Vifor
antitrust
Can Illumina Hold on to Grail?
Medical Devices and Diagnostics Industry
Tue, 08/2/22 - 12:01 am
Illumina
Grail
M&A
Europe
antitrust
Big tech firm Cadence expands to drug simulation software through $500M deal
MedCity News
Mon, 07/25/22 - 09:58 pm
R&D
Cadence Design Systems
OpenEye Scientific
M&A
7 months after announcing a pivot to drug discovery, Zymergen is acquired by Ginkgo
Fierce Biotech
Mon, 07/25/22 - 10:52 am
Zymergen
M&A
Ginkgo Bioworks
drug discovery
NewAmsterdam Pharma to Merge With SPAC Frazier Lifesciences
Marketwatch
Mon, 07/25/22 - 10:49 am
NewAmsterdam Pharma
M&A
SPAC
Frazier Lifesciences
Amazon primed to disrupt healthcare with purchase of One Medical
Medical Devices and Diagnostics Industry
Fri, 07/22/22 - 11:28 am
Amazon
M&A
primary care
One Medical
Silverback Therapeutics to merge with San Diego biotech company developing EpiPen alternative
Geekwire
Fri, 07/22/22 - 10:07 am
Silverback Therapeutics
M&A
ARS Pharmaceuticals
Ultragenyx buys gene therapy partner after new study results
BioPharma Dive
Tue, 07/19/22 - 10:45 am
Ultragenyz
gene therapy
M&A
Angelman Syndrome
GeneTx Biotherapeutics
EC’s Investigation into Illumina/Grail Merger Isn’t Stopping Anytime Soon
Medical Devices and Diagnostics Industry
Mon, 07/18/22 - 09:58 am
Illumina
Grail
Europe
M&A
GSK has a chance to prove itself after next week's Haleon split. Will M&A follow?
Fierce Pharma
Sun, 07/17/22 - 11:08 pm
GSK
spinoffs
Haleon
consumer health
M&A
Merck potential purchase of Seagen said unlikely by earnings date - report
Seeking Alpha
Sun, 07/17/22 - 11:05 pm
Merck
Seagen
earnings
M&A
Illumina loses challenge to block EU antitrust probe into $8B Grail buyout
Endpoints
Thu, 07/14/22 - 10:53 am
Illumina
M&A
Grail
Europe
antitrust
TherapeuticsMD shares crater as anticipated M&A deal falls through
Endpoints
Wed, 07/13/22 - 10:12 am
TherapeuticsMD
M&A
EW Healthcare Partners
Epizyme SEC filing details its desperate days in free fall before $247M sale to Ipsen
Fierce Pharma
Wed, 07/13/22 - 10:09 am
Epizyme
SEC
M&A
Ipsen
Medtronic lands option to buy artery disease player CathWorks for up to $585M
Medtech Dive
Wed, 07/13/22 - 10:04 am
devices
Medtech
Medtronic
CathWorks
M&A
coronary artery disease
Former Medtronic Consultant Faces Insider Trading Charges
Medical Devices and Diagnostics Industry
Tue, 07/12/22 - 11:32 pm
Medtronic
Medtech
devices
Mazor
M&A
insider trading
Pharma share prices: are we there yet?
EP Vantage
Tue, 07/12/22 - 10:40 am
M&A
pharma stocks
Pages
« first
‹ previous
…
26
27
28
29
30
31
32
33
34
…
next ›
last »